Rani Therapeutics Holdings (RANI) Shares Outstanding (2020 - 2026)

Rani Therapeutics Holdings has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $187.2 million in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 196.12% year-over-year to $187.2 million in Q2 2026; TTM through Jun 2026 was $187.2 million, a 196.12% increase from a year earlier, with the FY2025 full-year figure at $121.6 million, up 111.83% from the prior year.
• Shares Outstanding (Entity) was $187.2 million for Q2 2026 at Rani Therapeutics Holdings, up from $180.0 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $187.2 million in Q2 2026, with the low at $49.2 million in Q2 2022.
• Average Shares Outstanding (Entity) over 5 years is $71.7 million, with a median of $50.5 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Entity) decreased 7.95% in 2022, then surged 212.81% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $49.4 million in 2022, then advanced by 1.5% to $50.2 million in 2023, then advanced by 14.46% to $57.4 million in 2024, then soared by 111.83% to $121.6 million in 2025, then surged by 53.93% to $187.2 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $187.2 million (Q2 2026), $180.0 million (Q1 2026), and $121.6 million (Q4 2025), per Business Quant data.